Emergent BioSolutions Inc. (NYSE:EBS) stock is trading higher on Wednesday after the company announced the closing of a $100 million asset-backed revolving loan facility.
The Details: The new credit facility is aimed at enhancing Emergent's liquidity and providing additional financial flexibility to support its operational and strategic initiatives.
At at the end of September, Emergent had a cash balance of about $150 million. Through the new loan facility, Emergent now also has access to up to $100 million in financing.
"We are pleased to have successfully closed on our new ABL credit facility with favorable terms and an extended maturity, which is further evidence of Emergent's strengthened balance sheet and financial position," said Joe Papa, president and CEO of Emergent.
How To Buy Emergent BioSolutions Stock
By now you're likely curious about how to participate in the market for Emergent BioSolutions (NYSE:EBS) – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
EBS Price Action: At the time of writing, Emergent BioSolutions stock is trading 6.49% higher at $9.02, according to data from Benzinga Pro.
Image: 3196481 from Pixabay.